Discontinued — last reported Q1 '26
Europe, Middle East and Africa — Sales
Merck & Co. Europe, Middle East and Africa — Sales increased by 2.6% to $3.89B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.5%, from $3.45B to $3.89B. Over 4 years (FY 2021 to FY 2025), Europe, Middle East and Africa — Sales shows relatively stable performance with a 2.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests successful product launches, expanded market share, or favorable pricing dynamics in the region, while a decrease may indicate competitive pressure, regulatory headwinds, or economic downturns.
Detailed definition
This metric represents the total revenue generated from the sale of pharmaceutical products and services within the Euro...
Peer comparison
Comparable to regional revenue reporting by other multinational pharmaceutical companies, which often segment performance by major geographic theaters to highlight localized growth trends.
mrk_segment_europe_middle_east_and_africa_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.33B | $3.34B | $2.94B | $4.36B | $3.58B | $3.29B | $3.27B | $3.30B | $3.35B | $3.33B | $3.28B | $3.56B | $3.52B | $3.58B | $3.38B | $3.45B | $3.66B | $3.68B | $3.79B | $3.89B |
| QoQ Change | — | +0.3% | -12.1% | +48.4% | -17.8% | -8.3% | -0.6% | +1.1% | +1.4% | -0.6% | -1.5% | +8.8% | -1.3% | +1.9% | -5.7% | +2.2% | +5.9% | +0.6% | +2.9% | +2.6% |
| YoY Change | — | — | — | — | +7.5% | -1.7% | +11.2% | -24.2% | -6.5% | +1.2% | +0.3% | +7.9% | +5.0% | +7.7% | +3.2% | -3.1% | +4.1% | +2.7% | +12.0% | +12.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s europe, middle east and africa — sales?
- Merck & Co. (MRK) reported europe, middle east and africa — sales of $3.89B in Q1 2026.
- How has Merck & Co.'s europe, middle east and africa — sales changed year-over-year?
- Merck & Co.'s europe, middle east and africa — sales increased by 12.5% year-over-year, from $3.45B to $3.89B.
- What is the long-term trend for Merck & Co.'s europe, middle east and africa — sales?
- Over 4 years (2021 to 2025), Merck & Co.'s europe, middle east and africa — sales has grown at a 2.2% compound annual growth rate (CAGR), from $13.34B to $14.58B.
- What does europe, middle east and africa — sales mean?
- The total revenue earned by the company from its operations in the Europe, Middle East, and Africa region.